Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BinoViz is a Hong Kong-based visual technology company developing AI-driven image enhancement software built around its patented Binocular Video Tone Mapping (BVTM) technology. Its core product is designed to help people with color vision deficiency distinguish colors more effectively while preserving a natural viewing experience for non-color-blind users. The company positions BVTM as a cross-platform visual enhancement technology that can be deployed across screens, monitors, smart glasses, mobile devices, VR/AR applications, streaming media, and selected digital health use cases. Beyond accessibility, BinoViz also describes applications in medical, elderly care, media, and defense-related visual optimization. The company appears to operate as an active private company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BinoViz.